{"title_page": "Centalun", "text_new": "{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 424810107\n| IUPAC_name = 2-methyl-1-phenylbut-3-yne-1,2-diol\n| image = Centalun.svg\n| width = 180\n\n<!--Clinical data-->\n| tradename = \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category = \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->\n| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->\n| legal_status = Unscheduled\n| routes_of_administration = \n\n<!--Pharmacokinetic data-->\n| bioavailability = \n| protein_bound = \n| metabolism = \n| elimination_half-life = \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 2033-94-5\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 3N20VGJ39Y\n| ATC_prefix = none\n| ATC_suffix = \n| PubChem = 16252\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = \n| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}\n| ChemSpiderID = 15421\n| smiles = OC(c1ccccc1)C(C#C)(O)C\n| StdInChI_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChI = 1S/C11H12O2/c1-3-11(2,13)10(12)9-7-5-4-6-8-9/h1,4-8,10,12-13H,2H3\n| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChIKey = GQOXDWHRXDPZJK-UHFFFAOYSA-N\n\n<!--Chemical data-->\n| C=11 | H=12 | O=2 \n| molecular_weight = 176.212 g/mol\n}}\n\n'''Centalun''' was developed by Boehringer Ingelheim in 1962<ref>{{cite patent | country = BE | number = 618130 | title = Proc\u00e9d\u00e9 pour l'obtention d'alkinediols }}</ref> and is a [[psycholeptic]] drug with [[hypnotic]] and [[sedative]] effects, via [[allosteric]] agonism of the [[GABAA|GABA<sub>A</sub>]] receptor.<ref>{{cite journal | vauthors = Janke W, Glathe H | title = [Experimental Studies on the Psychic Effect of Sedatives Under Normal and Stress Conditions] | language = German | journal = Psychologische Forschung | volume = 27 | pages = 377\u2013402 | date = June 1964 | pmid = 14233519 | doi = 10.1007/bf00421338 }}</ref> It was previously used for sedation in medical procedures such as surgery,<ref>{{cite journal | vauthors = Monecke K | title = [Pre- and Postoperative Use of Centalun in Surgery] | language = German | journal = Deutsches Medizinisches Journal | volume = 15 | pages = 470\u20131 | date = July 1964 | pmid = 14238754 }}</ref> orthopedics<ref>{{cite journal | vauthors = Bruckschen E | title = [Sedative Therapy with Centalun in Orthopedics] | language = German | journal = Deutsches Medizinisches Journal | volume = 15 | pages = 493\u20134 | date = July 1964 | pmid = 14243120 }}</ref> and gynecology,<ref>{{cite journal | vauthors = Gerlach W, Gerlach E | title = [Experiences with Centalun in Obstetrical and Gynecological Patients] | language = German | journal = Medizinische Monatsschrift | volume = 18 | pages = 131\u20133 | date = March 1964 | pmid = 14193290 }}</ref> although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the [[Controlled substances act|CSA]] and therefore remains unregulated as a drug of abuse. \n\n== References ==\n{{reflist}}\n\n{{Hypnotics and sedatives}}\n{{GABAAR PAMs}}\n\n[[Category:Hypnotics]]\n[[Category:GABAA receptor positive allosteric modulators]]\n\n{{sedative-stub}}\n", "text_old": "{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 424810107\n| IUPAC_name = 2-methyl-1-phenylbut-3-yne-1,2-diol\n| image = Centalun.svg\n| width = 180\n\n<!--Clinical data-->\n| tradename = \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category = \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->\n| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->\n| legal_status = Unscheduled\n| routes_of_administration = \n\n<!--Pharmacokinetic data-->\n| bioavailability = \n| protein_bound = \n| metabolism = \n| elimination_half-life = \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 2033-94-5\n| ATC_prefix = none\n| ATC_suffix = \n| PubChem = 16252\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = \n| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}\n| ChemSpiderID = 15421\n| smiles = OC(c1ccccc1)C(C#C)(O)C\n| StdInChI_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChI = 1S/C11H12O2/c1-3-11(2,13)10(12)9-7-5-4-6-8-9/h1,4-8,10,12-13H,2H3\n| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChIKey = GQOXDWHRXDPZJK-UHFFFAOYSA-N\n\n<!--Chemical data-->\n| C=11 | H=12 | O=2 \n| molecular_weight = 176.212 g/mol\n}}\n\n'''Centalun''' was developed by Boehringer Ingelheim in 1962<ref>{{cite patent | country = BE | number = 618130 | title = Proc\u00e9d\u00e9 pour l'obtention d'alkinediols }}</ref> and is a [[psycholeptic]] drug with [[hypnotic]] and [[sedative]] effects, via [[allosteric]] agonism of the [[GABAA|GABA<sub>A</sub>]] receptor.<ref>{{cite journal | vauthors = Janke W, Glathe H | title = [Experimental Studies on the Psychic Effect of Sedatives Under Normal and Stress Conditions] | language = German | journal = Psychologische Forschung | volume = 27 | pages = 377\u2013402 | date = June 1964 | pmid = 14233519 | doi = 10.1007/bf00421338 }}</ref> It was previously used for sedation in medical procedures such as surgery,<ref>{{cite journal | vauthors = Monecke K | title = [Pre- and Postoperative Use of Centalun in Surgery] | language = German | journal = Deutsches Medizinisches Journal | volume = 15 | pages = 470\u20131 | date = July 1964 | pmid = 14238754 }}</ref> orthopedics<ref>{{cite journal | vauthors = Bruckschen E | title = [Sedative Therapy with Centalun in Orthopedics] | language = German | journal = Deutsches Medizinisches Journal | volume = 15 | pages = 493\u20134 | date = July 1964 | pmid = 14243120 }}</ref> and gynecology,<ref>{{cite journal | vauthors = Gerlach W, Gerlach E | title = [Experiences with Centalun in Obstetrical and Gynecological Patients] | language = German | journal = Medizinische Monatsschrift | volume = 18 | pages = 131\u20133 | date = March 1964 | pmid = 14193290 }}</ref> although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the [[Controlled substances act|CSA]] and therefore remains unregulated as a drug of abuse. \n\n== References ==\n{{reflist}}\n\n{{Hypnotics and sedatives}}\n{{GABAAR PAMs}}\n\n[[Category:Hypnotics]]\n[[Category:GABAA receptor positive allosteric modulators]]\n\n{{sedative-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Centalun"}
